Severe Asthma: Novel Concepts & Therapeutics
Event Date: April 26, 2019
Deadline to Submit Abstracts: March 8, 2019
Asthma is a chronic, heterogeneous inflammatory disease of the airways, affecting approximately 300 million people worldwide. Severe asthma is defined as an uncontrolled or only partially controlled form of asthma despite intensive treatment. It affects 5-10% of the adult asthma population and is associated with increased morbidity, mortality, and consumption of health care resources. Limited knowledge of the disease mechanisms is the greatest obstacle to the development of novel treatments. This symposium will focus on novel insights into the pathophysiology of severe asthma as well as on offering perspectives on potential new therapeutic opportunities.
To register for this event, please visit the main website at: www.nyas.org/severeasthma2019